RT Journal Article
T1 Incidence of Lymphoproliferative Disorders After Renal Transplantation is Down, but the Poor Prognosis Remains. Multicenter 32-Year Cohort Study.
A1 Franco, Antonio
A1 Hernandez, Domingo
A1 Mas-Serrano, Patricio
A1 Zarraga, Sofia
A1 Sanchez, Ana
A1 Crespo, Marta
A1 Mazuecos, Auxiliadora
A1 Diaz-Corte, Carmen
A1 Rodriguez-Benot, Alberto
A1 Jimenez, Carlos
A1 Gonzalez, Yussel
K1 Incidence
K1 Herpesvirus 4, Human
K1 Kidney Transplantation
K1 Epstein-Barr Virus Infections
AB Post-transplant lymphoproliferative disorders represent rare but serious complications of kidney transplantation. We assessed incidence, risk factors, and outcomes in 21,546 patients receiving grafts between 1990 and 2009. Data were compared by decade of transplant (1990-1999 vs 2000-2009). Patients were followed for at least 12 years over a 32-year study period. In total, 331 patients (1.5%) developed PTLD: 189 of 9740 transplanted in the first decade, and 142 of 11,806 in the second. Incidence decreased significantly (19.40 vs12.02 cases/1000 patients; P  Post-transplant lymphoproliferative disorders have a low and decreasing incidence, but the poor prognosis has not changed.
PB Elsevier
YR 2022
FD 2022-12-17
LK http://hdl.handle.net/10668/22536
UL http://hdl.handle.net/10668/22536
LA en
NO Franco A, Hernández D, Más-Serrano P, Zarraga S, Sanchez A, Crespo M, et al. Incidence of Lymphoproliferative Disorders After Renal Transplantation is Down, but the Poor Prognosis Remains. Multicenter 32-Year Cohort Study. Transplant Proc. 2022 Nov;54(9):2462-2466
DS RISalud
RD Apr 11, 2025